Study of High Risk Non Invasive Prenatal Test Population
- Conditions
- Trisomy 21
- Registration Number
- NCT04737070
- Lead Sponsor
- Central Hospital, Nancy, France
- Brief Summary
The investigator want to study the population of high risk (over 1/50) of Trisomy 21.
According to french guidelines, these patients needs to have a invasive test (such as amniocentesis) but some patients prefer to have a Non Invasive Prenatal Test, with a potential lack of information.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 150
Inclusion Criteria
- Prenatal screening of Trisomy 21 > 1/50 (high risk population)
Exclusion Criteria
- No exclusion criteria
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method number of genetics anomalies through study completion, an average of 9 months
- Secondary Outcome Measures
Name Time Method